MEI Pharma Earnings, Revenue miss In Q1

  • Investing.com
MEI Pharma Earnings, Revenue miss In Q1
Credit: © Reuters.

Investing.com - MEI Pharma reported on Thursday first quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.

MEI Pharma announced earnings per share of $-0.21 on revenue of $-603K. Analysts polled by Investing.com anticipated EPS of $-0.1925 on revenue of $4.78M.

MEI Pharma shares are down 80% from the beginning of the year and are trading at $0.527 , down-from-52-week-high.They are under-performing the Nasdaq which is down 24.18% from the start of the year.

MEI Pharma follows other major Healthcare sector earnings this month

MEI Pharma's report follows an earnings beat by Medtronic on Tuesday, August 23, 2022, who reported EPS of $1.13 on revenue of $7.37B, compared to forecasts EPS of $1.12 on revenue of $7.22B.

Agilent Technologies had beat expectations on Tuesday, August 16, 2022 with third quarter EPS of $1.34 on revenue of $1.72B, compared to forecast for EPS of $1.2 on revenue of $1.64B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100